Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Natural Bioactive Compounds As Protectors Of Mitochondrial Dysfunction In Cardiovascular Diseases And Aging.

Arauna D, Furrianca M, Espinosa-Parrilla Y, Fuentes E, Alarcón M, Palomo I.

Molecules. 2019 Nov 22;24(23). pii: E4259. doi: 10.3390/molecules24234259. Review.

2.

Antiplatelet Activity of Natural Bioactive Extracts from Mango (Mangifera Indica L.) and its By-Products.

Alañón ME, Palomo I, Rodríguez L, Fuentes E, Arráez-Román D, Segura-Carretero A.

Antioxidants (Basel). 2019 Oct 29;8(11). pii: E517. doi: 10.3390/antiox8110517.

3.

Oxidative pathways of arachidonic acid as targets for regulation of platelet activation.

Trostchansky A, Moore-Carrasco R, Fuentes E.

Prostaglandins Other Lipid Mediat. 2019 Dec;145:106382. doi: 10.1016/j.prostaglandins.2019.106382. Epub 2019 Oct 18. Review.

PMID:
31634570
4.

Antiplatelet protocol: Effects of ingesting a tomato pomace extract on human platelet aggregation.

Concha-Meyer A, Fuentes E, Palomo I.

MethodsX. 2019 Aug 24;6:1847-1853. doi: 10.1016/j.mex.2019.08.012. eCollection 2019.

5.

Increased platelet function during frailty.

Hernández B, Fuentes E, Palomo I, Alarcón M.

Exp Hematol. 2019 Sep;77:12-25.e2. doi: 10.1016/j.exphem.2019.08.006. Epub 2019 Aug 30.

PMID:
31476327
6.

Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders.

Espinosa-Parrilla Y, Gonzalez-Billault C, Fuentes E, Palomo I, Alarcón M.

Front Aging Neurosci. 2019 Jul 2;11:151. doi: 10.3389/fnagi.2019.00151. eCollection 2019. Review.

7.

Role of Platelet Activation and Oxidative Stress in the Evolution of Myocardial Infarction.

Fuentes E, Moore-Carrasco R, de Andrade Paes AM, Trostchansky A.

J Cardiovasc Pharmacol Ther. 2019 Nov;24(6):509-520. doi: 10.1177/1074248419861437. Epub 2019 Jul 7.

PMID:
31280622
8.

Lipid Metabolism and Signaling in Platelet Function.

Paes AMA, Gaspar RS, Fuentes E, Wehinger S, Palomo I, Trostchansky A.

Adv Exp Med Biol. 2019;1127:97-115. doi: 10.1007/978-3-030-11488-6_7. Review.

PMID:
31140174
9.

Methodology of generation and purification of anti-beta 2 glycoprotein I antibodies.

Alarcon M, Fuentes E, Maldonado X, Mardones C, Palomo I.

MethodsX. 2019 Apr 29;6:986-992. doi: 10.1016/j.mex.2019.04.023. eCollection 2019.

10.

Chemical Characterization and Antiplatelet Potential of Bioactive Extract from Tomato Pomace (Byproduct of Tomato Paste).

Palomo I, Concha-Meyer A, Lutz M, Said M, Sáez B, Vásquez A, Fuentes E.

Nutrients. 2019 Feb 22;11(2). pii: E456. doi: 10.3390/nu11020456.

11.

Roles of Phenolic Compounds in the Reduction of Risk Factors of Cardiovascular Diseases.

Lutz M, Fuentes E, Ávila F, Alarcón M, Palomo I.

Molecules. 2019 Jan 21;24(2). pii: E366. doi: 10.3390/molecules24020366. Review.

12.

Regulation of mitochondrial function as a promising target in platelet activation-related diseases.

Fuentes E, Araya-Maturana R, Urra FA.

Free Radic Biol Med. 2019 May 20;136:172-182. doi: 10.1016/j.freeradbiomed.2019.01.007. Epub 2019 Jan 6. Review.

PMID:
30625393
13.

Analysis of the characteristics and components for the frailty syndrome in older adults from central Chile. The PIEI-ES study.

Palomo I, Giacaman RA, León S, Lobos G, Bustamante M, Wehinger S, Tapia JC, Fuentes M, Alarcón M, García F, Albala C, Fuentes E.

Arch Gerontol Geriatr. 2019 Jan - Feb;80:70-75. doi: 10.1016/j.archger.2018.10.004. Epub 2018 Oct 18.

PMID:
30390427
14.

Platelet mitochondrial dysfunction and mitochondria-targeted quinone-and hydroquinone-derivatives: Review on new strategy of antiplatelet activity.

Fuentes M, Araya-Maturana R, Palomo I, Fuentes E.

Biochem Pharmacol. 2018 Oct;156:215-222. doi: 10.1016/j.bcp.2018.08.035. Epub 2018 Aug 25. Review.

PMID:
30149016
15.

Spatial analysis for the epidemiological study of cardiovascular diseases: A systematic literature search.

Mena C, Sepúlveda C, Fuentes E, Ormazábal Y, Palomo I.

Geospat Health. 2018 May 7;13(1):587. doi: 10.4081/gh.2018.587. Review.

16.

NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis.

Fuentes E, Gibbins JM, Holbrook LM, Palomo I.

Trends Cardiovasc Med. 2018 Oct;28(7):429-434. doi: 10.1016/j.tcm.2018.03.001. Epub 2018 Mar 26. Review.

PMID:
29661712
17.

Buddleja globosa (matico) prevents collagen-induced platelet activation by decreasing phospholipase C-gamma 2 and protein kinase C phosphorylation signaling.

Fuentes M, Sepúlveda C, Alarcón M, Palomo I, Fuentes E.

J Tradit Complement Med. 2017 Mar 19;8(1):66-71. doi: 10.1016/j.jtcme.2017.02.005. eCollection 2018 Jan.

18.

Impact of walkability with regard to physical activity in the prevention of diabetes.

Mena C, Sepúlveda C, Ormazábal Y, Fuentes E, Palomo I.

Geospat Health. 2017 Nov 3;12(2):595. doi: 10.4081/gh.2017.595. Review.

PMID:
29239549
19.

Docking and quantitative structure-activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors.

Muñoz-Gutiérrez C, Cáceres-Rojas D, Adasme-Carreño F, Palomo I, Fuentes E, Caballero J.

PLoS One. 2017 Dec 7;12(12):e0189213. doi: 10.1371/journal.pone.0189213. eCollection 2017.

20.

Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses.

Matus MF, Vilos C, Cisterna BA, Fuentes E, Palomo I.

Vascul Pharmacol. 2018 Feb;101:1-8. doi: 10.1016/j.vph.2017.11.004. Epub 2017 Nov 22. Review.

PMID:
29174014

Supplemental Content

Loading ...
Support Center